| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
| Ramanujam, Nirmala |
Duke University
United States |
Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening |
5U01CA269192-02 |